Ultrasound of the lungs may unmask hidden heart failure in COPD patients
NCT ID NCT05352490
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study tests whether a simple lung ultrasound can accurately detect heart failure in people with chronic obstructive pulmonary disease (COPD) who come to the emergency room with shortness of breath. Heart failure is a common but often missed cause of worsening COPD symptoms. Researchers will measure ultrasound patterns (A-lines and B-lines) in 350 patients and compare them to standard diagnostic methods to see how well the ultrasound works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If lung ultrasound proves accurate, it could become a quick, bedside tool to detect hidden heart failure in COPD patients, leading to faster, more targeted treatment.
- What could go wrong
- This is a diagnostic accuracy study, not a treatment trial. The ultrasound method may not be reliable enough in all patients, and results may not change outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
350 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
May 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with history of COPD admitted to the emergency departmet for dyspnea
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients with history of COPD admitted to the emergency department for dyspnea non traumatic dyspnea Exclusion Criteria: * instable hemodynamic or neurological status non consent to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emergency Departement
Monastir, 5000, Tunisia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A phase II, randomized, Double-Blind, Placebo-Controlled study to assess the efficacy and safety of lebrikizumab in patients with chronic obstructive pulmonary disease and a history of exacerbations
- RESP-FIT: a respiratory muscle strength training intervention for COPD
- The role of volumetric High-Resolution computed tomography (HRCT) of the chest in the assessment of patients with stable chronic obstructive pulmonary disease (COPD)
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- Fine-Mist inhalers aim to reach deep lungs in COPD
- App alerts COPD patients when their inhalers may be out of date